Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway.
Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway.
复制标题
Squamosamide 衍生物 FLZ 通过刺激 Akt-FOXO1 途径保护胰腺 β 细胞免受糖毒性
DOI:
10.1155/2015/803986
复制
发表时间:
2015
影响因子:
4.3
通讯作者:
Ma X
中科院分区:
文献类型:
--
作者:
Kong X;Zhang L;Hua X;Ma X
Chronic hyperglycemia increases apoptosis and reduces glucose-stimulated insulin secretion. Although protective agents have been searched extensively, none has been found so far. Here we tested FLZ, a synthetic derivative of squamosamide from a Chinese herb, as a potential candidate for antiglucotoxicity in INS-1E cells and mouse islets. Chronic culture of β-cells in 30 mM glucose caused progressive reduction of cell viability, accompanied with increased apoptosis and reduced insulin secretion. These effects on apoptosis and insulin were reversed by FLZ in a dose-dependent manner. FLZ treatment also increased forkhead box O1 protein phosphorylation and reduced its nuclear location. On the contrary, FLZ increased pancreatic and duodenal homeobox-1 expression and its nuclear localization, an effect mediated by increased p-Akt. Consistently, Akt selective inhibitor MK-2206 completely abolished antiglucotoxicity effect of FLZ. Furthermore, FLZ treatment increased cytosolic ATP/ADP ratio. Taken together, our results suggest that FLZ could be a potential therapeutic agent to treat the hyperglycemia-induced β-cell failure.
登录
查看更多内容
影响因子:
8.2
作者:
Kluth, O.;Mirhashemi, F.;Scherneck, S.;Kaiser, D.;Kluge, R.;Neschen, S.;Joost, H. -G.;Schuermann, A.
通讯作者:
Schuermann, A.
影响因子:
--
作者:
Lim, Sangbin;Rashid, Md Abdur;Kim, Sung Soo
通讯作者:
Kim, Sung Soo
影响因子:
2.9
作者:
Bao, Xiu-Qi;Kong, Xiang-Chen;Zhang, Dan
通讯作者:
Zhang, Dan
影响因子:
4.1
作者:
Hou, Zhi-Qiang;Li, Hong-Liang;Li, Guang-Wei
通讯作者:
Li, Guang-Wei
影响因子:
7.7
作者:
Park, Keun-Gyu;Lee, Kyeong-Min;Lee, In-Kyu
通讯作者:
Lee, In-Kyu